Clinical Evaluation of Bioactive Resin Composites Versus Caries Control Technique in Management of Class I Carious Cavities in High Caries Risk Patients: a Randomized Clinical Trial
Launched by CAIRO UNIVERSITY · Jan 27, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into different types of dental fillings to see which ones work better for patients who are at a high risk of tooth decay. Specifically, it will compare two new types of resin composites—S-PRG based and Alkasite based—to traditional resin fillings. The study will focus on filling cavities in the back teeth (molars) that are not too deep and will follow the patients for one year to see how well these fillings hold up.
To participate in this trial, you need to be an adult between the ages of 21 and 50 who has a high risk of cavities and is likely to return for follow-up visits. Only certain kinds of back teeth with specific types of decay will be included in the study. However, if you have any serious health issues, are pregnant or breastfeeding, or have certain dental conditions, you may not be eligible to join. If you decide to take part, you can expect to have your cavity treated with one of the filling materials and will be asked to return for check-ups to see how well it is working over time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient inclusion:
- • 1. Adult Patients (Male or Females) aging ≥21-50 years.
- • 2. Patients with high level of caries risk.
- • 3. Patients with good likelihood of recall availability.
- Tooth inclusion:
- • 1- Permanent posterior molar teeth with primary simple occlusal Class I carious lesions (ICDAS 3 or 4 scores) 3- 2- Vital, periodontally sound and with positive reaction to cold stimulus. 4- 3-Well-formed and fully erupted in normal functional occlusion with natural antagonist and adjacent teeth
- Exclusion Criteria:
- • - Participants with general/systemic illness. 2- Pregnant or lactating females. 3- Concomitant participation in another research study. 4- Inability to comply with study procedures. 5- Heavy bruxism habits. 6- Last experience with allergic reactions against any components of the used materials.
- • 7- Patients receiving orthodontic treatment.
- Tooth exclusion:
- • 1. Teeth with clinical symptoms of pulpitis such as spontaneous pain or sensitivity to pressure.
- • 2. Non-vital teeth, Fractured or cracked teeth.
- • 3. Secondary carious lesions.
- • 4. Hypocalcified or hypoplastic teeth.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported